CC1C(OS(=O)(=O)c2ccc3nc(S)sc3c2)CC2C3(C)CCC2(C(C)C(=O)O)C(O)C13
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?